Avalia Immunotherapies Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Liquidation

Avalia Immunotherapies General Information

Description

Developer of immune system modulators designed to support cancer treatment. The company's modulators help in the treatment of cancer, influenza, allergy, and other diseases and also offer therapeutic vaccines that direct powerful immune cells in the body for targeted responses to disease, enabling healthcare providers to activate immune cells in the patient's body and to improve clinical outcomes for cancer and infectious disease.

Contact Information

Website
www.avaliaimmunotherapies.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Gate 7, Victoria University Central Services Building
  • Kelburn
  • Wellington, 6012
  • New Zealand
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Gate 7, Victoria University Central Services Building
  • Kelburn
  • Wellington, 6012
  • New Zealand

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avalia Immunotherapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 10-Oct-2023 Completed Bankruptcy: Liquidation
5. Later Stage VC Completed Pre-Clinical Trials
4. Grant 01-May-2020 Completed Pre-Clinical Trials
3. Early Stage VC 10-May-2016 Completed Startup
2. Seed Round $450K Completed Startup
1. Accelerator/Incubator 11-Sep-2015 $450K $450K Completed Startup
To view Avalia Immunotherapies’s complete valuation and funding history, request access »

Avalia Immunotherapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Avalia Immunotherapies FAQs

  • When was Avalia Immunotherapies founded?

    Avalia Immunotherapies was founded in 2015.

  • Where is Avalia Immunotherapies headquartered?

    Avalia Immunotherapies is headquartered in Wellington, New Zealand.

  • What is the size of Avalia Immunotherapies?

    Avalia Immunotherapies has 3 total employees.

  • What industry is Avalia Immunotherapies in?

    Avalia Immunotherapies’s primary industry is Biotechnology.

  • Is Avalia Immunotherapies a private or public company?

    Avalia Immunotherapies is a Private company.

  • What is Avalia Immunotherapies’s current revenue?

    The current revenue for Avalia Immunotherapies is .

  • How much funding has Avalia Immunotherapies raised over time?

    Avalia Immunotherapies has raised $2.52M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »